6541.TW
Price:
$60.6
Market Cap:
$16.05B
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Industry
Biotechnology
IPO Date
2015-08-13
Stock Exchange
TAI
Ticker
6541.TW
According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.20B. This represents a change of 30.62% compared to the average of 12.40B of the last 4 quarters.
The mean historical Enterprise Value of Tanvex BioPharma, Inc. over the last ten years is 15.56B. The current 16.20B Enterprise Value has changed 10.31% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's Enterprise Value was at its highest in in the June 2016 quarter at 29.52B. The Enterprise Value was at its lowest in in the March 2020 quarter at 6.04B.
Average
15.56B
Median
11.92B
Minimum
8.90B
Maximum
31.90B
Discovering the peaks and valleys of Tanvex BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.47%
Maximum Annual Enterprise Value = 31.90B
Minimum Annual Increase = -56.99%
Minimum Annual Enterprise Value = 8.90B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 11.39B | 16.94% |
| 2023 | 9.74B | -27.45% |
| 2022 | 13.43B | -27.21% |
| 2021 | 18.45B | 94.49% |
| 2020 | 9.48B | 6.52% |
| 2019 | 8.90B | -23.24% |
| 2018 | 11.60B | -5.26% |
| 2017 | 12.24B | -56.99% |
| 2016 | 28.47B | -10.76% |
| 2015 | 31.90B | 166.47% |
The current Enterprise Value of Tanvex BioPharma, Inc. (6541.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.52B
5-year avg
12.50B
10-year avg
15.56B
Tanvex BioPharma, Inc.’s Enterprise Value is greater than Ever Supreme Bio Technology Co., Ltd (14.20B), greater than Foresee Pharmaceuticals Co., Ltd. (11.85B), greater than Medigen Vaccine Biologics Corporation (12.45B), greater than Excelsior Medical Co., Ltd. (13.54B), greater than AP Biosciences Inc (12.24B), greater than YungShin Global Holding Corporation (15.23B), greater than PharmaEngine, Inc. (8.99B), greater than Acepodia, Inc. (4.31B), less than EirGenix Inc. (17.73B), greater than ScinoPharm Taiwan, Ltd. (11.68B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.20B | $14.37B | |
| 11.85B | $12.36B | |
| 12.45B | $12.34B | |
| 13.54B | $14.02B | |
| 12.24B | $13.53B | |
| 15.23B | $15.29B | |
| 8.99B | $10.49B | |
| 4.31B | $9.15B | |
| 17.73B | $19.22B | |
| 11.68B | $13.76B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tanvex BioPharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?
What is the 3-year average Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?
What is the 5-year average Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?
How does the current Enterprise Value for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?